Showing results (61-70 of 854) with videos related to
Sort By:
Pageof 86
The Lancet. Neurology|July 10, 2003
Inflammation in multiple sclerosis: the good, the bad, and the complexGianvito Martino, Luciano Adorini, Peter Rieckmann, et al.Immunology Letters|March 31, 2010
Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel diseaseGilles Laverny, Giuseppe Penna, Stefania Vetrano, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2004
Selection of similar naive T cell repertoires but induction of distinct T cell responses by native and modified antigenFrancesco Ria, Alexandra Gallard, Claudia Raja Gabaglia, et al.The Journal of Biological Chemistry|June 10, 2017
A dual agonist of farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5, INT-767, reverses age-related kidney disease in miceXiaoxin X Wang, Yuhuan Luo, Dong Wang, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|June 26, 2025
Farnesoid X receptor inhibits proinflammatory cytokine-induced epithelial necroptosis in vitro: implications for preservation of intestinal barrier functionCaitriona E Curley, Natalia K Lajczak-McGinley, Luciano Adorini, et al.Molecular Aspects of Medicine|December 17, 2013
Clinical application of transcriptional activators of bile salt transportersAnna Baghdasaryan, Peter Chiba, Michael TraunerSeminars in Liver Disease|November 14, 2013
Bile acid-mediated control of liver triglyceridesClaudia Fuchs, Thierry Claudel, Michael TraunerNature Clinical Practice. Gastroenterology & Hepatology|September 30, 2006
Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsisAndreas Geier, Peter Fickert, Michael TraunerDigestive Diseases (Basel, Switzerland)|March 2, 2017
Nor-Ursodeoxycholic Acid as a Novel Therapeutic Approach for Cholestatic and Metabolic Liver DiseasesEmina Halilbasic, Daniel Steinacher, Michael TraunerDigestive Diseases (Basel, Switzerland)|March 2, 2017
Therapeutic Mechanisms of Bile Acids and Nor-Ursodeoxycholic Acid in Non-Alcoholic Fatty Liver DiseaseDaniel Steinacher, Thierry Claudel, Michael TraunerPageof 86